Non-Opioid Pain Treatment Market is Estimated to Boom worldwide with a USD 807.32 million During the Forecast Period 2029
Non-Opioid Pain Treatment Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.
Pain management is an essential part of medical treatment. Migraine, lower back pain, osteoarthritis, fibromyalgia, localised musculoskeletal pain, and localised neuropathic pain are all examples of chronic pain syndromes. While opioids may be acceptable for acute or chronic pain related to palliative or end-of-life care, as well as current cancer therapy, there are also non-opioid pain management choices. Non-opioid pain treatment is an option for mild to moderate pain. Non-opioid pain relief is available without a prescription and as over-the-counter medications.
Data Bridge Market Research analyses that the non-opioid pain treatment market which was USD 622.65 million in 2021, would rocket up to USD 807.32 million by 2029, and is expected to undergo a CAGR of 3.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Non-opioid pain relievers are a form of pain reliever that has been specifically created to manage mild to moderate pain. They’re commonly used to treat neuropathic pain, cancer pain, orthopaedic and musculoskeletal pain, and other conditions. Medical cannabis, botulinum toxins, capsaicin derivatives, and other non-opioid pain treatments are among the most common.
Download Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-non-opioid-pain-treatment-market
Non-Opioid Pain Treatment Market Dynamics
Drivers
Increasing prevalence of osteoarthritis
The rising global prevalence of osteoarthritis, fueled by the ageing population, joint injuries, obesity, repeated stress on the joint, genetics, metabolic illnesses, and bone abnormalities, is expected to fuel demand for non-opioid pain treatment patches. It is the most prevalent type of arthritis, and it most commonly affects the knees, hips, and hands. According to the Osteoarthritis Action Alliance (OAAA), approximately 54.4 million adults in the United States have some type of arthritis, with that number anticipated to rise to 78 million by 2040. Osteoarthritis affects roughly 32.5 million persons in the United States. This tendency is expected to continue in many regions of the world in the future years, propelling the market forward.
Increasing cases of cancer
Breast, bowel, colorectal, and lung cancer cases are predicted to increase in the next years, propelling the industry forward. The market is expected to benefit from increased awareness among governments in various countries about the availability of novel non-opioid heat patches for the treatment of cancer-related pain. According to the World Health Organization (WHO), cancer will kill approximately 10 million people worldwide in 2020. Breast cancer claimed over 6,85, 000 lives in the same year, while liver cancer claimed 8,30,000 lives and lung cancer claimed 1.80 million lives. This showcases that the prevalence of cancer is set to surge at a fast pace in the near future, which would drive the market.
High cases of chronic pain-related conditions
The rising prevalence of chronic pain in India is expected to push the non-opioid pain patch market in South Asia. The market is expected to benefit from the government’s increasing investments in the construction of a well-established healthcare infrastructure to treat pain-related disorders. Scientists from the All India Institute of Medical Sciences and the Homi Bhabha National Institute, for example, undertook a study in December 2018 to better understand the effect and magnitude of chronic pain across Southeast Asia. A total of 4326 Indian patients were screened, with 836 of them completing a pain questionnaire. Females had a higher incidence (25.2%) than males, and the prevalence increased dramatically among persons aged 65 and up. The numbers are estimated to grow in the near future, thereby augmenting the demand for non-opioid heat patches in India.
Opportunities
Another important factor expected to boost the market is the growing demand for non-opioid pain management patches due to their ability to reduce the risk of addiction when compared to fentanyl patches when released over a lengthy period of time. In the foreseeable future, the rising demand for minimally invasive therapies is likely to boost growth.
Global Non-Opioid Pain Treatment Market Scope
The non-opioid pain treatment market is segmented on the basis of product, therapeutic application and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Medical Cannabis
Menthol-Containing
Omega 3 Fatty Acid-Containing
Botulinum Toxins
Capsaicin-Derived
Others
Therpaeutic application
Orthopaedic and Musculoskeletal Pain
Neuropathic Pain
Cancer Pain
Post-operative Pain
Others
Distribution channel
Hospitals Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
To Get a Detailed Table of Contents (TOC), please Click Here at @ https://www.databridgemarketresearch.com/toc/?dbmr=global-non-opioid-pain-treatment-market
Non-Opioid Pain Treatment Market Regional Analysis/Insights
The non-opioid pain treatment market is analysed and market size insights and trends are provided by country, product, therapeutic application and distribution channel as referenced above.
The countries covered in the non-opioid pain treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the non- opioid pain treatment market due to growing clinical trials and increasing funding by the government.
Asia-Pacific is expected to show significant growth, due to changing economic demographic which improves the drug affordability, rising health insurance and low cost of production and R&D boosts efficiency of pharmaceutical companies in the emerging countries such as India.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Non-Opioid Pain Treatment Market Share Analysis
The non-opioid pain treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to non-opioid pain treatment market.
Some of the major players operating in the non-opioid pain treatment market are:
Eli Lilly and company (U.S.)
Regeneron Pharmaceuticals Inc. (U.S.)
Centrexion Therapeutics Corp. (U.S.)
Acorda Therapeutics (U.S.)
Biogen (U.S.)
VM Biotech (U.S.)
Novartis AG (Switzerland)
Alder Biopharmaceuticals (U.S.)
Sanofi (France)
Pfizer Inc. (U.S.)
GSK plc. (U.K.)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Clarion (U.S.)
Endo Pharmaceuticals (Ireland)
TEH SENG PHARMACEUTICAL MFG. CO., LTD. (Taiwan)
Veridian Healthcare (U.S.)
Sorrento Therapeutics, Inc. (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Teikoku Seiyaku Co. Ltd. (Japan)
Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-non-opioid-pain-treatment-market
Research Methodology:
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Top Trendings Reports:-
https://www.databridgemarketresearch.com/reports/global-vendor-neutral-archive-vna-market
https://www.databridgemarketresearch.com/reports/global-anesthesia-monitoring-devices-market
https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market
https://www.databridgemarketresearch.com/reports/global-cell-permeabilization-market
https://www.databridgemarketresearch.com/reports/global-tangential-flow-filtration-market
About Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”
Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
